ArticleDiscover oncology2025
Integrated network toxicology and molecular simulations uncover the molecular mechanism and core targets of DNBaP-induced lung cancer.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Deep learning-based structural prediction (AlphaFold 3) of shrimp IMNV RdRp and identification of seaweed-derived metabolites for antiviral intervention in aquaculture.Virus research · 2026Article
- The effects of nicotine exposure on depression: An integrative analysis combining network toxicology, molecular docking, and Mendelian randomization.Tobacco induced diseases · 2026Article
- An integrative pharmacovigilance, network toxicology and molecular docking study on drug-induced cheilitis.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aims to comprehensively apply network toxicology and molecular dynamics simulation techniques to investigate the molecular mechanisms of DNBaP-induced lung cancer. We first predicted the toxicological characteristics of DNBaP related to carcinogenicity. Subsequently, by integrating multiple databases, 71 potential cross-targets of DNBaP-induced lung cancer were screened. GO analysis and KEGG pathway enrichment analysis of these targets verified their functions in biological processes and signaling pathways, further confirming their association with lung cancer. Using these potential cross-targets, a STRING interaction network was constructed, and five core genes were identified through Cytoscape software. Molecular docking was performed to predict the binding affinity between DNBaP and these core genes. Finally, molecular dynamics simulations were conducted to further validate the stability of the complexes and infer how the biological functions of the protein structures are affected after complex formation. This study systematically reveals the molecular mechanism of DNBaP-induced lung cancer: it disrupts intracellular homeostasis by interfering with core genes (CDKN2A, EGFR, ESR1, TNF, TP53) and activating key signaling pathways such as PI3K-Akt and MAPK. The research demonstrates the effectiveness and feasibility of integrating network toxicology, molecular docking, and molecular dynamics simulation techniques in assessing the toxic mechanisms of environmental pollutants. It provides an important theoretical basis and scientific methodology for understanding the health risks of DNBaP, screening new targets for lung cancer intervention, and developing preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.